105 related articles for article (PubMed ID: 9176749)
1. Cyclin D1, p53, mdm2, and Ki67 protein expression in preneoplastic lesions of the larynx.
Capaccio P; Carboni N; Pignataro L; Scotti A; Ottaviani F; Pruneri G
J Chemother; 1997 Apr; 9(2):113-4. PubMed ID: 9176749
[No Abstract] [Full Text] [Related]
2. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
4. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
[TBL] [Abstract][Full Text] [Related]
6. The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma.
Liu CJ; Chang KW; Chao SY; Kwan PC; Chang SM; Yen RY; Wang CY; Wong YK
J Oral Pathol Med; 2004 Jul; 33(6):327-34. PubMed ID: 15200480
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of p53, MDM-2, cyclin D1 and Ki67 in the progression from low-grade dysplasia towards carcinoma of the larynx.
Pignataro L; Capaccio P; Pruneri G; Carboni N; Buffa R; Neri A; Ottaviani A
J Laryngol Otol; 1998 May; 112(5):455-9. PubMed ID: 9747474
[TBL] [Abstract][Full Text] [Related]
8. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract][Full Text] [Related]
9. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
Mielcarek-Kuchta D; Olofsson J; Golusinski W
Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p63, p53 and ki67 expression in laryngeal basaloid squamous cell carcinomas.
Calli C; Calli A; Pinar E; Oncel S; Tatar B
B-ENT; 2011; 7(1):37-42. PubMed ID: 21563555
[TBL] [Abstract][Full Text] [Related]
11. mdm-2 oncoprotein expression associated with deletion of the long arm of chromosome 12 in a case of mantle cell lymphoma with blastoid transformation [corrected].
Haidar JH; Neiman RS; Orazi A; Albitar M; McCarthy LJ; Heerema N
Mod Pathol; 1996 Apr; 9(4):355-9. PubMed ID: 8729971
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.
Holgersson G; Ekman S; Reizenstein J; Bergqvist M; Pontén F; Uhlén M; Magnusson K; Jonnalagadda P; Asplund A; Strömberg S; Linder A; Blomquist E; Liljeholm M; Lödén B; Hellström K; Bergström S
Cancer Genomics Proteomics; 2010; 7(1):1-7. PubMed ID: 20181625
[TBL] [Abstract][Full Text] [Related]
14. p53 and MDM2 protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract.
Ambrosch P; Ruschenburg I
Anticancer Res; 2000; 20(5A):3151-5. PubMed ID: 11062736
[TBL] [Abstract][Full Text] [Related]
15. MDM2 expression is associated with progress of disease and WAF1 expression in resected lung cancer.
Aikawa H; Sato M; Fujimura S; Takahashi H; Endo C; Sakurada A; Chen Y; Kondo T; Tanita T; Matsumura Y; Saito Y; Sagawa M
Int J Mol Med; 2000 Jun; 5(6):631-3. PubMed ID: 10812014
[TBL] [Abstract][Full Text] [Related]
16. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence.
Hakin-Smith V; Battersby RD; Maltby EL; Timperley WR; Royds JA
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):40-9. PubMed ID: 11299001
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p53 and MDM2 proteins in cervical neoplasia.
Lukás Z; Vojtĕsek B; Anton M; Picksley SM; Kubálek V
Folia Biol (Praha); 1995; 41(3-4):197-9. PubMed ID: 7589715
[TBL] [Abstract][Full Text] [Related]
20. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]